vs

Side-by-side financial comparison of ExlService Holdings, Inc. (EXLS) and Teradyne (TER). Click either name above to swap in a different company.

Teradyne is the larger business by last-quarter revenue ($1.1B vs $542.6M, roughly 2.0× ExlService Holdings, Inc.). Teradyne runs the higher net margin — 23.7% vs 11.1%, a 12.6% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (43.9% vs 12.7%). Teradyne produced more free cash flow last quarter ($218.8M vs $106.5M). Over the past eight quarters, Teradyne's revenue compounded faster (34.4% CAGR vs 11.5%).

Exlservice Holdings, Inc. is a global analytics and digital solutions company serving industries including insurance, healthcare, banking and financial services, media, retail, and others. The company is headquartered in New York and has more than 54,000 professionals in locations throughout the United States, Europe, Asia, Latin America, Australia and South Africa.

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

EXLS vs TER — Head-to-Head

Bigger by revenue
TER
TER
2.0× larger
TER
$1.1B
$542.6M
EXLS
Growing faster (revenue YoY)
TER
TER
+31.2% gap
TER
43.9%
12.7%
EXLS
Higher net margin
TER
TER
12.6% more per $
TER
23.7%
11.1%
EXLS
More free cash flow
TER
TER
$112.2M more FCF
TER
$218.8M
$106.5M
EXLS
Faster 2-yr revenue CAGR
TER
TER
Annualised
TER
34.4%
11.5%
EXLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EXLS
EXLS
TER
TER
Revenue
$542.6M
$1.1B
Net Profit
$60.2M
$257.2M
Gross Margin
38.6%
57.2%
Operating Margin
14.4%
27.1%
Net Margin
11.1%
23.7%
Revenue YoY
12.7%
43.9%
Net Profit YoY
18.9%
75.9%
EPS (diluted)
$0.38
$1.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXLS
EXLS
TER
TER
Q4 25
$542.6M
$1.1B
Q3 25
$529.6M
$769.2M
Q2 25
$514.5M
$651.8M
Q1 25
$501.0M
$685.7M
Q4 24
$481.4M
$752.9M
Q3 24
$472.1M
$737.3M
Q2 24
$448.4M
$729.9M
Q1 24
$436.5M
$599.8M
Net Profit
EXLS
EXLS
TER
TER
Q4 25
$60.2M
$257.2M
Q3 25
$58.2M
$119.6M
Q2 25
$66.1M
$78.4M
Q1 25
$66.6M
$98.9M
Q4 24
$50.7M
$146.3M
Q3 24
$53.0M
$145.6M
Q2 24
$45.8M
$186.3M
Q1 24
$48.8M
$64.2M
Gross Margin
EXLS
EXLS
TER
TER
Q4 25
38.6%
57.2%
Q3 25
38.5%
58.4%
Q2 25
37.7%
57.2%
Q1 25
38.6%
60.6%
Q4 24
38.1%
59.4%
Q3 24
37.8%
59.2%
Q2 24
37.1%
58.3%
Q1 24
37.4%
56.6%
Operating Margin
EXLS
EXLS
TER
TER
Q4 25
14.4%
27.1%
Q3 25
14.4%
18.9%
Q2 25
15.8%
13.9%
Q1 25
15.7%
17.6%
Q4 24
14.8%
20.4%
Q3 24
14.7%
20.6%
Q2 24
13.7%
28.8%
Q1 24
14.1%
13.0%
Net Margin
EXLS
EXLS
TER
TER
Q4 25
11.1%
23.7%
Q3 25
11.0%
15.5%
Q2 25
12.8%
12.0%
Q1 25
13.3%
14.4%
Q4 24
10.5%
19.4%
Q3 24
11.2%
19.8%
Q2 24
10.2%
25.5%
Q1 24
11.2%
10.7%
EPS (diluted)
EXLS
EXLS
TER
TER
Q4 25
$0.38
$1.62
Q3 25
$0.36
$0.75
Q2 25
$0.40
$0.49
Q1 25
$0.40
$0.61
Q4 24
$0.31
$0.89
Q3 24
$0.33
$0.89
Q2 24
$0.28
$1.14
Q1 24
$0.29
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXLS
EXLS
TER
TER
Cash + ST InvestmentsLiquidity on hand
$328.4M
$293.8M
Total DebtLower is stronger
$298.6M
Stockholders' EquityBook value
$912.7M
$2.8B
Total Assets
$1.7B
$4.2B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXLS
EXLS
TER
TER
Q4 25
$328.4M
$293.8M
Q3 25
$390.1M
$272.7M
Q2 25
$353.3M
$339.3M
Q1 25
$331.4M
$475.6M
Q4 24
$340.6M
$553.4M
Q3 24
$325.8M
$510.0M
Q2 24
$276.1M
$421.9M
Q1 24
$246.2M
$707.4M
Total Debt
EXLS
EXLS
TER
TER
Q4 25
$298.6M
Q3 25
$354.8M
Q2 25
$260.0M
Q1 25
$307.3M
Q4 24
$288.5M
Q3 24
$344.7M
Q2 24
Q1 24
Stockholders' Equity
EXLS
EXLS
TER
TER
Q4 25
$912.7M
$2.8B
Q3 25
$952.4M
$2.7B
Q2 25
$1.1B
$2.8B
Q1 25
$1.0B
$2.8B
Q4 24
$929.9M
$2.8B
Q3 24
$907.6M
$2.9B
Q2 24
$852.6M
$2.7B
Q1 24
$803.3M
$2.6B
Total Assets
EXLS
EXLS
TER
TER
Q4 25
$1.7B
$4.2B
Q3 25
$1.7B
$4.0B
Q2 25
$1.7B
$3.8B
Q1 25
$1.7B
$3.7B
Q4 24
$1.6B
$3.7B
Q3 24
$1.6B
$3.8B
Q2 24
$1.5B
$3.6B
Q1 24
$1.4B
$3.4B
Debt / Equity
EXLS
EXLS
TER
TER
Q4 25
0.33×
Q3 25
0.37×
Q2 25
0.25×
Q1 25
0.30×
Q4 24
0.31×
Q3 24
0.38×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXLS
EXLS
TER
TER
Operating Cash FlowLast quarter
$117.4M
$281.6M
Free Cash FlowOCF − Capex
$106.5M
$218.8M
FCF MarginFCF / Revenue
19.6%
20.2%
Capex IntensityCapex / Revenue
2.0%
5.8%
Cash ConversionOCF / Net Profit
1.95×
1.09×
TTM Free Cash FlowTrailing 4 quarters
$298.1M
$450.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXLS
EXLS
TER
TER
Q4 25
$117.4M
$281.6M
Q3 25
$120.7M
$49.0M
Q2 25
$109.4M
$182.1M
Q1 25
$3.2M
$161.6M
Q4 24
$105.3M
$282.6M
Q3 24
$110.1M
$166.3M
Q2 24
$74.9M
$216.1M
Q1 24
$-21.9M
$7.3M
Free Cash Flow
EXLS
EXLS
TER
TER
Q4 25
$106.5M
$218.8M
Q3 25
$106.4M
$2.4M
Q2 25
$95.0M
$131.7M
Q1 25
$-9.7M
$97.6M
Q4 24
$95.3M
$225.2M
Q3 24
$97.3M
$114.4M
Q2 24
$62.8M
$171.2M
Q1 24
$-33.1M
$-36.7M
FCF Margin
EXLS
EXLS
TER
TER
Q4 25
19.6%
20.2%
Q3 25
20.1%
0.3%
Q2 25
18.5%
20.2%
Q1 25
-1.9%
14.2%
Q4 24
19.8%
29.9%
Q3 24
20.6%
15.5%
Q2 24
14.0%
23.5%
Q1 24
-7.6%
-6.1%
Capex Intensity
EXLS
EXLS
TER
TER
Q4 25
2.0%
5.8%
Q3 25
2.7%
6.1%
Q2 25
2.8%
7.7%
Q1 25
2.6%
9.3%
Q4 24
2.1%
7.6%
Q3 24
2.7%
7.0%
Q2 24
2.7%
6.1%
Q1 24
2.6%
7.3%
Cash Conversion
EXLS
EXLS
TER
TER
Q4 25
1.95×
1.09×
Q3 25
2.08×
0.41×
Q2 25
1.66×
2.32×
Q1 25
0.05×
1.63×
Q4 24
2.08×
1.93×
Q3 24
2.08×
1.14×
Q2 24
1.63×
1.16×
Q1 24
-0.45×
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXLS
EXLS

Insurance$185.8M34%
Healthcare And Life Sciences$142.2M26%
Banking Capital Markets And Diversified Industries$122.6M23%
International Growth Markets$92.0M17%

TER
TER

Soc$646.5M60%
Memory$206.5M19%
Transferred At Point In Time$90.0M8%
Universal Robots$89.4M8%
IST$30.5M3%
Transferred Over Time$20.5M2%

Related Comparisons